tetano
Editor, Senior Moderator
Vaccine. 2018 Jun 27. pii: S0264-410X(18)30889-2. doi: 10.1016/j.vaccine.2018.06.048. [Epub ahead of print]
[h=1]Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.[/h] Ping X[SUP]1[/SUP], Hu W[SUP]1[/SUP], Xiong R[SUP]2[/SUP], Zhang X[SUP]3[/SUP], Teng Z[SUP]3[/SUP], Ding M[SUP]2[/SUP], Li L[SUP]1[/SUP], Chang C[SUP]1[/SUP], Xu K[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] H1N1, one of the most prevalent influenza A virus subtypes affecting the human population, can cause infections varying from mild respiratory syndrome to severe pneumonia. The current H1N1 vaccine needs to be updated annually and does not protect against future outbreaks. Here, we downloaded 2,656 HA protein sequences of human H1N1 viruses from the NCBI influenza database (up to the date of Aug. 2012) and constructed a phylogenetic tree of these H1 proteins via the neighbor-joining method using MEGA 5.0 software. A consensus H1 protein (CH1) was generated and was further modified with published conserved T-cell and B-cell epitopes. Interestingly, this CH1 protein is genetically similar to an H1 isolate obtained during the 1980s (A/Memphis/7/1980), indicating that a universal HA antigen may exist in nature. Vaccination with a DNA vaccine expressing CH1 elicited broadly reactive T-cell and B-cell responses to heterologous H1N1 viruses, though this vaccine did not successfully neutralize pdm09 H1N1 viruses. A combination of CH1 and pdm09 HA in a DNA vaccination neutralized pdm09 H1N1 viruses and protected mice from lethal infections by all representative H1N1 viruses. Moreover, a recombinant chimeric PR8-CH1 virus carrying HA sequence of the consensus H1 and all other seven genes from the PR8 strain was highly attenuated in mice, with a lethal dose (LD[SUB]50[/SUB]) of more than 10[SUP]6[/SUP] pfu. Vaccination with PR8-CH1 virus provided complete protection against infections by heterologous H1N1 strains. Taken together, a universal H1 antigen, CH1, was developed by constructing a consensus HA sequence, and the PR8-CH1 virus containing this consensus sequence elicited broadly protective immunity against heterologous H1N1 viruses.
[h=4]KEYWORDS:[/h] Broad-reactive; Consensus sequence; Influenza A virus
PMID: 29960799 DOI: 10.1016/j.vaccine.2018.06.048
[h=1]Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence.[/h] Ping X[SUP]1[/SUP], Hu W[SUP]1[/SUP], Xiong R[SUP]2[/SUP], Zhang X[SUP]3[/SUP], Teng Z[SUP]3[/SUP], Ding M[SUP]2[/SUP], Li L[SUP]1[/SUP], Chang C[SUP]1[/SUP], Xu K[SUP]4[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] H1N1, one of the most prevalent influenza A virus subtypes affecting the human population, can cause infections varying from mild respiratory syndrome to severe pneumonia. The current H1N1 vaccine needs to be updated annually and does not protect against future outbreaks. Here, we downloaded 2,656 HA protein sequences of human H1N1 viruses from the NCBI influenza database (up to the date of Aug. 2012) and constructed a phylogenetic tree of these H1 proteins via the neighbor-joining method using MEGA 5.0 software. A consensus H1 protein (CH1) was generated and was further modified with published conserved T-cell and B-cell epitopes. Interestingly, this CH1 protein is genetically similar to an H1 isolate obtained during the 1980s (A/Memphis/7/1980), indicating that a universal HA antigen may exist in nature. Vaccination with a DNA vaccine expressing CH1 elicited broadly reactive T-cell and B-cell responses to heterologous H1N1 viruses, though this vaccine did not successfully neutralize pdm09 H1N1 viruses. A combination of CH1 and pdm09 HA in a DNA vaccination neutralized pdm09 H1N1 viruses and protected mice from lethal infections by all representative H1N1 viruses. Moreover, a recombinant chimeric PR8-CH1 virus carrying HA sequence of the consensus H1 and all other seven genes from the PR8 strain was highly attenuated in mice, with a lethal dose (LD[SUB]50[/SUB]) of more than 10[SUP]6[/SUP] pfu. Vaccination with PR8-CH1 virus provided complete protection against infections by heterologous H1N1 strains. Taken together, a universal H1 antigen, CH1, was developed by constructing a consensus HA sequence, and the PR8-CH1 virus containing this consensus sequence elicited broadly protective immunity against heterologous H1N1 viruses.
[h=4]KEYWORDS:[/h] Broad-reactive; Consensus sequence; Influenza A virus
PMID: 29960799 DOI: 10.1016/j.vaccine.2018.06.048